Islet amyloid polypeptide: Aggregation and fibrillogenesis in vitro and its inhibition

Subcellular Biochemistry

Volumn 65, Issue , 2012, Pages 185-209

  Seeliger, Janine ^a   Winter, Roland ^a  

^a TU DORTMUND UNIVERSITY   (Germany)

Author keywords

Aggregation; Islet amyloid polypeptide; Model biomembranes; Small molecule inhibitors; Type 2 diabetes mellitus

Indexed keywords

AMYLIN; MULTIPROTEIN COMPLEX;

ANIMAL; CHEMISTRY; HUMAN; LIPID BILAYER; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOLOGY; PROTEIN SECONDARY STRUCTURE; REVIEW;

ANIMALS; DIABETES MELLITUS, TYPE 2; HUMANS; ISLET AMYLOID POLYPEPTIDE; LIPID BILAYERS; MULTIPROTEIN COMPLEXES; PROTEIN STRUCTURE, SECONDARY;

EID: 84893009611     PISSN: 03060225     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-94-007-5416-4_8     Document Type: Article

References (53)

1. Andrews MN,Winter R (2011) Comparing the structural properties of human and rat islet amyloid polypeptide by MD computer simulations. Biophys Chem 156:43-50
2. Brittes J, Lúcio M, Nunes C, Lima JLFC, Reis S (2010) Effects of resveratrol on membrane biophysical properties: relevance for its pharmacological effects. Chem Phys Lipids 163:747-754
3. Bulic B, Pickhardt M, Khlistunova I, Biernat J, MandelkowEM, MandelkowE,WaldmannH (2007) Rhodanine-based tau aggregation inhibitors in cell models of tauopathy. Angew Chem Int Ed 46:9215-9219
4. Butterfield SM, Lashuel HA (2010) Amyloidogenic protein-membrane interactions: mechanistic insight from model systems. Angew Chem Int Ed 49:5628-5654
5. Clark A, Lewis CE,WillisAC, Cooper GJS, Morris JF, Reid KBM, Turner RC (1987) Islet amyloid formed from diabetes-associated peptide may be pathogenic in type-2 diabetes. Lancet 330:231- 234
6. Clément L, Kim-Sohn KA, Magnan C, Kassis N, Adnot P, Kergoat M, Assimacopoulos-Jeannet F, Pénicaud L, Hsu FF, Turk J, Ktorza A (2002) Pancreatic β-Cell σ2A Adrenoceptor and Phospholipid Changes in Hyperlipidemic Rats. Lipids 37:501-506
7. Cooper GJS,Willis AC, Clark A, Turner RC, Sim RB, Reid KBM (1987) Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. Proc Natl Acad Sci U S A 84:8628-8632
8. Cooper GJS, Leighton B, Dimitriadis GD, Parry-Billings M, Kowalchuk JM, Howland K, Rothbard JB, Willis AC, Reid KBM (1988) Amylin found in amyloid deposits in human type 2 diabetes mellitus may be a hormone that regulates glycogen metabolism in skeletal muscle. Proc Natl Acad Sci U S A 85:7763-7766
9. Engel MFM, Khemtémourian L, Kleijer CC, Meeldijk HJ, Jacobs J,VerkleijAJ, de Kruijff B, Killian JA, Höppener JW (2008) Membrane damage by human islet amyloid polypeptide through fibril growth at the membrane. Proc Natl Acad Sci U S A 105:6033-6038
10. Evers F, Jeworrek C, Tiemeyer S,Weise K, Sellin D, Paulus M, Struth B, Tolan M,Winter R (2009) Elucidating the mechanism of lipid membrane-induced IAPP fibrillogenesis and its inhibition by the red wine compound resveratrol: a synchrotron X-ray reflectivity study. J Am Chem Soc 131:9516-9521
11. Goldsbury C, Goldie K, Pellaud J, Seelig J, Frey P, Müller SA, Kistler J, Cooper GJ, Aebi U (2000) Amyloid fibril formation from full-length and fragments of amylin. J Struct Biol 130:352-362
12. Gurlo T, Ryazantsev S, Huang CJ,Yeh MW, Reber HA, Hines OJ, O'Brien TD, Glabe CG, Butler PC (2010) Evidence for proteotoxicity in beta cells in type 2 diabetes: toxic islet amyloid polypeptide oligomers form intracellularly in the secretory pathway.Am J Pathol 176:861-869
13. Hebda JA, MirankerAD (2009) The interplay of catalysis and toxicity by amyloid intermediates on lipid bilayers: insights from type II diabetes. Annu Rev Biophys 38:125-152
14. Hull RL, Westermark GT, Westermark P, Kahn SE (2004) Islet amyloid: a critical entity in the pathogenesis of type 2 diabetes. J Clin Endocrinol Metab 89:3629-3643
15. Janson J, Ashley RH, Harrison D, McIntyre S, Butler PC (1999) The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles. Diabetes 48:491-498
16. Jayasinghe SA, Langen R (2007) Membrane interaction of islet amyloid polypeptide. Biochim Biophys Acta Biomembr 1768:2002-2009
17. Jha S, Sellin D, Seidel R, Winter R (2009) Amyloidogenic propensities and conformational properties of proIAPP and IAPP in the presence of lipid bilayer membranes. J Mol Biol 389:907-920
18. Jiang P, Li W, Shea JE, Mu Y (2011) Resveratrol inhibits the formation of multiple-layered sheet oligomers of the human islet amyloid polypeptide segment 22-27. Biophys J 100:1550-1558
19. Johnson KH, O'Brien TD, Betsholtz C, Westermark P (1992) Islet amyloid polypeptide: mechanisms of amyloidogenesis in the pancreatic islets and potential roles in diabetes mellitus. Lab Invest 66:522-535
20. Kakio A, Nishimoto S,Yanagisawa K, KozutsumiY, Matsuzaki K (2002) Interactions of amyloid β- protein with various gangliosides in raft-like membranes: importance ofGM1ganglioside-bound form as an endogenous seed for Alzheimer amyloid. Biochemistry 41:7385-7390
21. Kapoor S, Werkmüller A, Denter C, Zhai Y, Markgraf J, Weise K, Opitz N, Winter R (2011) Temperature-pressure phase diagram of a heterogeneous anionic model biomembrane system: results from a combined calorimetry, spectroscopy and microscopy study. Biochim Biophys Acta Biomembr 1808:1187-1195
22. Kayed R, Bernhagen J, Greenfield N, Sweimeh K, Brunner H, Voelter W, Kapurniotu A (1999) Conformational transitions of islet amyloid polypeptide (IAPP) in amyloid formation in vitro. J Mol Biol 287:781-796
23. Knight JD, Miranker AD (2004) Phospholipid catalysis of diabetic amyloid assembly. J Mol Biol 341:1175-1187
24. Leighton B, Cooper GJS (1988) Pancreatic amylin and calcitonin gene-related peptide cause resistance to insulin in skeletal muscle in vitro. Nature 335:632-635
25. Lopes DHJ, Meister A, Gohlke A, Hauser A, BlumeA,Winter R (2007) Mechanism of islet amyloid polypeptide fibrillation at lipid interfaces studied by infrared reflection absorption spectroscopy. Biophys J 93:3132-3141
26. Marzban L, Soukhatcheva G, Verchere CB (2005) Role of carboxypeptidase E in processing of pro-islet amyloid polypeptide in β-cells. Endocrinology 146:1808-1817
27. Merglen A, Theander S, Rubi B, Chaffard G, Wollheim CB, Maechler P (2004) Glucose sensitivity and metabolism-secretion coupling studied during two-year continuous culture in INS-1E insulinoma cells. Endocrinology 145:667-678
28. Mirzabekov TA, Lin MC, Kagan BL (1996) Pore formation by the cytotoxic islet amyloid peptide amylin. J Biol Chem 271:1988-1992
29. Mishra R, Bulic B, Sellin D, Jha S, Waldmann H, Winter R (2008) Small-molecule inhibitors of islet amyloid polypeptide fibril formation. Angew Chem Int Ed 47:4679-4682
30. Mishra R, Geyer M, Winter R (2009a) NMR spectroscopic investigation of early events in IAPP amyloid fibril formation. ChemBioChem 10:1769-1772
31. Mishra R, Sellin D, Radovan D, Gohlke A,Winter R (2009b) Inhibiting islet amyloid polypeptide fibril formation by the red wine compound resveratrol. ChemBioChem 10:445-449
32. Naiki H, Higuchi K, Hosokawa M, Takeda T (1989) Fluorometric determination of amyloid fibrils in vitro using the fluorescent dye, thioflavine T. Anal Biochem 177:244-249
33. Nishi M, Sanke T, Nagamatsu S, Bell GI, Steiner DF (1990) Islet amyloid polypeptide-a new β-cell secretory product related to islet amyloid deposits. J Biol Chem 265:4173-4176
34. Opie EL (1901) The relation of diabetes mellitus to lesions of the pancreas: hyaline degeneration of the islets of Langerhans. J Exp Med 5:527-540
35. PoratY,Kolusheva S, Jelinek R, Gazit E (2003) The human islet amyloid polypeptide forms transient membrane-active prefibrillar assemblies. Biochemistry 42:10971-10977
36. Porat Y, Abramowitz A, Gazit E (2006) Inhibition of amyloid fibril formation by polyphenols: structural similarity and aromatic interactions as a common inhibition mechanism. Chem Biol Drug Des 67:27-37
37. Radovan D, Opitz N,WinterR (2009) Fluorescence microscopy studies on islet amyloid polypeptide fibrillation at heterogeneous and cellular membrane interfaces and its inhibition by resveratrol. FEBS Lett 583:1439-1445
38. Rauch S, FacklerOT (2007)Viruses, lipid rafts and signal transduction. SignalTransduction 7:53-63
39. Sanke T, Bell GI, Sample C, Rubenstein AH, Steiner DF (1988) An islet amyloid peptide is derived from an 89-amino acid precursor by proteolytic processing. J Biol Chem 263:17243-17246
40. Seeliger J, Evers F, Jeworrek C, Kapoor S,Weise K, Andreetto E, Tolan M, Kapurniotu A,Winter R (2012a) Cross-amyloid interaction of Aβ and IAPP at lipid membranes. Angew Chem Int Ed 51:679-683
41. Seeliger J,Weise K, Opitz N,WinterR (2012b) The effect ofAβ on IAPP aggregation in the presence of an isolated β-cell membrane. J Mol Biol 421:348-363
42. Sellin D,Yan LM, Kapurniotu A,Winter R (2010) Suppression of IAPP fibrillation at anionic lipid membranes via IAPP-derived amyloid inhibitors and insulin. Biophys Chem 150:73-79
43. Staubach S, Hanisch FG (2011) Lipid rafts: signaling and sorting platforms of cells and their roles in cancer. Expert Rev Proteomics 8:263-277
44. Turk J, Wolf BA, Lefkowith JB, Stump WT, McDaniel ML (1986) Glucose-induced phospholipid hydrolysis in isolated pancreatic islets: quantitative effects on the phospholipid content of arachidonate and other fatty acids. Biochim Biophys Acta Lipids Lipid Metab 879:399-409
45. Wakabayashi M, Matsuzaki K (2007) Formation of amyloids by Abeta-(1-42) on NGFdifferentiated PC12 cells: roles of gangliosides and cholesterol. J Mol Biol 371:924-933
46. Weichselbaum A, Stangl E (1901) Zur Kenntnis der feineren Veränderungen des Pankreas bei Diabetes mellitus.Wien KleinWochenschr 14:968-972
47. Weise K, Radovan D, Gohlke A, Opitz N, Winter R (2010a) Interaction of hIAPP with model raft membranes and pancreatic β-cells: cytotoxicity of hIAPP oligomers. ChemBioChem 11:1280- 1290
48. Weise K, Triola G, Janosch S,Waldmann H,Winter R (2010b) Visualizing association of lipidated signaling proteins in heterogeneous membranes-partitioning into subdomains, lipid sorting, interfacial adsorption, and protein association. Biochim Biophys Acta Biomembr 1798:1409- 1417
49. Westermark P (1973) Fine structure of islets of Langerhans in insular amyloidosis. Virchows Arch A Pathol Anat 359:1-18
50. Westermark P (2011) Amyloid in the islets of Langerhans: thoughts and some historical aspects. Upsala J Med Sci 116:81-89
51. Westermark P, Wernstedt C, Wilander E, Hayden DW, O'Brien TD, Johnson KH (1987) Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells. Proc Natl Acad Sci U SA 84:3881- 3885
52. Westermark G,Westermark P, Eizirik DL, Hellerström C, Fox N, Steiner DF, Andersson A (1999) Differences in amyloid deposition in islets of transgenic mice expressing human islet amyloid polypeptide versus human islets implanted into nude mice. Metabolism 48:448-454
53. Yan LM, Velkova A, Tatarek-Nossol M, Andreetto E, Kapurniotu A (2007) IAPP mimic blocks Aβ cytotoxic self-assembly: cross-suppression of amyloid toxicity of Ab and IAPP suggests a molecular link between Alzheimer's disease and type II diabetes. Angew Chem Int Ed 46:1246- 1252